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https://doi.org/10.1016/j.neuron.2019.05.015SUMMARY
A crucial step in understanding the sleep-control
mechanism is to identify sleep neurons. Through sys-
tematic anatomical screening followed by functional
testing, we identified two sleep-promoting neuronal
populations along a thalamo-amygdala pathway,
both expressing neurotensin (NTS). Rabies-medi-
ated monosynaptic retrograde tracing identified the
central nucleus of amygdala (CeA) as a major source
of GABAergic inputs to multiple wake-promoting
populations; gene profiling revealed NTS as a prom-
inent marker for these CeA neurons. Optogenetic
activation and inactivation of NTS-expressing CeA
neurons promoted and suppressed non-REM
(NREM) sleep, respectively, and optrode recording
showed they are sleep active. Further tracing
showed that CeA GABAergic NTS neurons are inner-
vated by glutamatergic NTS neurons in a posterior
thalamic region, which also promote NREM sleep.
CRISPR/Cas9-mediated NTS knockdown in either
the thalamic or CeA neurons greatly reduced their
sleep-promoting effect. These results reveal a novel
thalamo-amygdala circuit for sleep generation in
which NTS signaling is essential for both the up-
stream glutamatergic and downstream GABAergic
neurons.
INTRODUCTION
A well-studied brain region for sleep generation is the preoptic
area of the anterior hypothalamus (Nauta, 1946; Von Economo,
1930) in which a subset of GABAergic neurons promotes sleep
by inhibiting wake-promoting neuronal populations (Chung
et al., 2017; Lu et al., 2000; Sallanon et al., 1989; Sherin et al.,
1998; Steininger et al., 2001; Zhang et al., 2015). In addition to
the preoptic area, recent studies have identified sleep-promot-
ing neurons in posterior parts of the hypothalamus (Jego et al.,
2013; Konadhode et al., 2013; Liu et al., 2017; Tsunematsu
et al., 2014), the parafacial zone in the medulla (Anaclet et al.,2014), the basal ganglia (Oishi et al., 2017; Yuan et al., 2017),
the ventral tegmental area (VTA) (Yang et al., 2018; Yu et al.,
2019), and the ventrolateral periaqueductal gray (Weber et al.,
2015). This indicates that the sleep-control network is widely
distributed, spanning multiple anatomical locations. Given the
diversity of brain regions involved, however, it is unclear how
many additional sleep-promoting neurons remain to be discov-
ered and whether there is any organizational logic of the sleep-
control network. To address these questions, we employed a
three-step approach for systematic identification of sleep-pro-
moting neurons consisting of anatomical screening, marker
identification, and functional validation.
In principle, a neuron could promote sleep by either inhibiting
wake-promoting neurons (Brown et al., 2012; Saper et al., 2010;
Scammell et al., 2017; Weber and Dan, 2016) or exciting other
sleep-promotingneurons.Basedon thissimple logic,wedesigned
a strategy for whole-brain screening for candidate sleep neurons.
Using rabies virus (RV)-mediated transsynaptic tracing, we first
identified GABAergic neurons that broadly inhibit multiple wake-
promoting neuronal populations. To gain genetic access to these
candidate sleepneurons,we identified theirmolecularmarkers us-
ing gene-expression profiling. The role of these neurons in sleep
regulation was then tested using bidirectional optogenetic manip-
ulation. Once functionally validated, theGABAergic sleep neurons
were targeted for further RV tracing, and their glutamatergic inputs
were tested as additional candidate sleep neurons.
This sequential screening approach led to the identification of
two neuronal populations along a thalamo-amygdala pathway
that promote non-REM (NREM) sleep. Interestingly, both the
GABAergic and glutamatergic populations express the peptide
neurotensin (NTS). CRISPR/Cas9-mediated knockdown of
either NTS or the vesicular transporter for GABA and glutamate
strongly reduced the sleep-promoting effect of each population,
indicating that these neurons promote NREM sleep using both
classical transmitters and the neuropeptide NTS.
RESULTS
Detection of Candidate Sleep Neurons in the Central
Nucleus of Amygdala
To identify candidate sleep neurons that inhibit wake-pro-
moting neurons, we performed RV-mediated transsynaptic
tracing from seven wake-promoting populations, includingNeuron 103, 1–12, July 17, 2019 ª 2019 Elsevier Inc. 1
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Figure 1. Detection of Candidate Sleep Neurons in the CeA through Anatomical Screening
(A) Schematic for identifying candidate sleep neurons that inhibit multiple wake-promoting populations using RV-mediated retrograde tracing.
(B) Percentage of RV-labeled GABAergic neurons in each presynaptic region for each targeted wake-promoting population. Included are presynaptic regions
with >5 RV-labeled cells for at least 3 of the targeted wake populations. Presynaptic regions too close to the starter cell population are excluded from the analysis
due to potential local contamination (Beier et al., 2015; Weissbourd et al., 2014) (e.g., preoptic area [POA] for basal forebrain [BF] targeting), indicated by black.
BNST, bed nucleus of the stria terminalis; LS, lateral septum; SNr, substantia nigra pars reticulata; ZI, zona incerta.
(C) CeA GABAergic neurons innervate multiple wake-promoting populations. Left: coronal diagrams showing virus injection sites and Cre lines used for RV
tracing. Right: fluorescence images of RV-labeled presynaptic neurons in CeA with progressively higher magnification (white box in each image shows the region
enlarged in the next image on the right). Arrowheads indicate overlap between RV-EGFP (green) and Gad1/2 (red). Scale bars represent 800 mm (left), 100 mm
(middle), or 25 mm (right). BF, basal forebrain; PPT, pedunculopontine tegmentum; TMN, tuberomammillary nucleus.
See also Figure S1.
Please cite this article in press as: Ma et al., Sleep Regulation by Neurotensinergic Neurons in a Thalamo-Amygdala Circuit, Neuron (2019), https://
doi.org/10.1016/j.neuron.2019.05.015noradrenergic, histaminergic, cholinergic, glutamatergic, and
GABAergic neurons distributed in the brainstem, hypothala-
mus, and basal forebrain (Brown et al., 2012; Saper et al.,
2010; Scammell et al., 2017; Weber and Dan, 2016). An avian
retroviral receptor (TVA) fused with mCherry (TC) and a rabies
glycoprotein (RG) was expressed in each population by inject-
ing two Cre-inducible adeno-associated virus (AAV) vectors
(AAV2-CAG-FLEx-TC and AAV2-CAG-FLEx-RG) into the target
region of the corresponding Cre mice (Figure 1A). A modified
RV expressing EGFP (RVdG-EGFP+EnvA) was injected 3 weeks
later to infect the TC-expressing target neurons (Figure S1) and2 Neuron 103, 1–12, July 17, 2019label their presynaptic inputs (Weissbourd et al., 2014; Wicker-
sham et al., 2007).
Fluorescence in situ hybridization (FISH) combinedwith immu-
nohistochemistry (IHC) ofGad1/2 (glutamate decarboxylase 1 or
2) and RV-EGFP revealed several brain regions with broad
GABAergic innervation of the wake-promoting populations (Fig-
ure 1B), including the preoptic hypothalamus and zona incerta,
both of which contain GABAergic sleep-promoting neurons
(Chung et al., 2017; Liu et al., 2017; Lu et al., 2000; Sherin
et al., 1998; Steininger et al., 2001; Zhang et al., 2015). Surpris-
ingly, however, the most prominent source of GABAergic inputs
Please cite this article in press as: Ma et al., Sleep Regulation by Neurotensinergic Neurons in a Thalamo-Amygdala Circuit, Neuron (2019), https://
doi.org/10.1016/j.neuron.2019.05.015was found in a posterior part of the central nucleus of amygdala
(CeA), especially its lateral subdivision (CeL) (Figure 1C). In fact,
in addition to the wake-promoting populations targeted here, the
CeA also innervates serotonergic neurons in the dorsal raphe
(Weissbourd et al., 2014) and dopaminergic neurons in the VTA
(Beier et al., 2015; Eban-Rothschild et al., 2016). Such broad
GABAergic innervation of wake-promoting populations points
to CeA neurons as strong candidates for sleep-promoting
neurons.
NTS Is a Marker for CeA Candidate Sleep Neurons
The CeA is known to contain multiple subtypes of GABAergic
neurons with distinct molecular markers, projection targets,
and functional properties (Cai et al., 2014; Carter et al., 2013;
Ciocchi et al., 2010; Douglass et al., 2017; Fadok et al., 2017;
Haubensak et al., 2010; Janak and Tye, 2015; Kim et al., 2017;
Li et al., 2013; McCall et al., 2015; Viviani et al., 2011; Zelikowsky
et al., 2018). To identify molecular markers for the neurons pro-
jecting to the wake-promoting populations, we performed gene
profiling using translating ribosome affinity purification (TRAP)
(Ekstrand et al., 2014; Heiman et al., 2008). Cre-inducible herpes
simplex virus (HSV) expressing the large ribosomal subunit
protein Rpl10a fused with a FLAG and hemagglutinin (HA) tag
(HSV-hEF1a-LSL-FlagHA-L10a) was injected into the locus co-
eruleus (LC) and parabrachial nucleus (PB) of Gad2Cre mice. Af-
ter 30–45 days of expression, the CeA was dissected, and the
translating mRNA was isolated by immunoprecipitating (IP) the
L10a protein from tissue lysate (Figure 2A).
RNA sequencing (RNA-seq) revealed multiple genes signifi-
cantly enriched in immunoprecipitated RNAs from the LC- and
PB-projecting CeA GABAergic neurons relative to the input
RNAs (whole CeA lysates before immunoprecipitation; Fig-
ure 2B). In particular, we focused on the genes encoding neuro-
peptides, which are known to play important roles in behavioral
regulation and serve as useful markers for cell types (Paul et al.,
2017). We found three highly enriched neuropeptides, tachykinin
2 (TAC2), NTS, and prodynorphin (PDYN), all of which are
strongly expressed in the CeA, but not in the nearby basolateral
amygdala. In contrast, none of the highly enriched non-peptide
markers (Figure 2B) exhibit restricted expression in the CeA
(based on in situ hybridization data from the Allen Mouse Brain
Atlas, Allen Institute for Brain Science: https://mouse.brain-
map.org/). Double FISH in the posterior CeA showed a near-
complete overlap between TAC2 and NTS and a strong overlap
between PDYN and NTS (Kim et al., 2017) (Figure 2C). The ma-
jority of RV-labeled CeA neurons projecting to the LC, PB, or
VTA expressed NTS (Figure 2D), but very few expressed PKCd
or enkephalin (Figure 2E), even though they are also prominent
markers in the CeA (Haubensak et al., 2010; Kim et al., 2017).
This is consistent with the gene profiling experiment showing
that PKCd and enkephalin are not enriched in the LC- and PB-
projecting neurons relative to the input RNAs (Figure 2B). These
results point to NTS as an effective marker for the candidate
sleep neurons, allowing specific targeting of these cells using a
knockin NtsCre mouse line (Leinninger et al., 2011) (Figure S2A).
Whole-cell recordings in acute brain slices confirmedGABAergic
innervation of several wake-promoting cell types by CeA NTS
neurons (Figures S2B–S2E).CeA NTS Neurons Are NREM Promoting and NREM
Active
To test the causal role of the CeA NTS neurons in sleep gen-
eration, we injected Cre-inducible AAV expressing ChR2
fused with enhanced yellow fluorescent protein (ChR2-EYFP)
into the posterior CeA of NtsCre mice. Laser stimulation
(10 Hz, 120 s per trial) was applied randomly every 7–16 min
in freely moving mice, and wake, REM, and NREM sleep
was classified based on electroencephalogram (EEG) and
electromyogram (EMG) recordings. Activation of CeA NTS
neurons during the light phase caused a marked increase in
NREM sleep and decrease in wakefulness (Figures 3A and
3B), and the EEG power spectrum during the laser-induced
NREM state was indistinguishable from that during sponta-
neous NREM sleep outside of laser stimulation (Figure S3A).
Immunohistochemical staining of Fos showed that the magni-
tude of increase in NREM sleep depends strongly on the
number of CeA neurons activated by the laser (Figure S3B).
To determine whether the increased NREM sleep was due
to its increased initiation or maintenance, we analyzed the
probability of transitions between each pair of brain states
(Chung et al., 2017). NTS neuron activation significantly
increased wake/NREM and NREM/NREM transitions while
decreasing wake/wake, NREM/wake, and NREM/REM
transitions (Figure 3C), indicating enhancement of both the
initiation and maintenance of NREM sleep. Furthermore, opto-
genetic activation of NTS neurons during the dark phase also
increased NREM sleep (Figures S3C; p < 0.0001, bootstrap),
although the magnitude of the increase was smaller than
that during the light phase (p = 0.01).
In contrast to ChR2-mediated activation, optogenetic
silencing of CeA NTS neurons through the light-activated chlo-
ride channel iC++ significantly decreased NREM sleep and
increased wakefulness (Figures 3D and 3E). These changes
were caused by a decreased NREM/NREM transition and
increased NREM/wake and NREM/REM transitions (Fig-
ure 3F). In control mice expressing EYFP without ChR2 or
iC++, laser stimulation had no effect (Figures S3D and S3E),
and the laser-induced changes in sleep and wakefulness
were significantly different between ChR2 and control mice
(p < 0.01, bootstrap) and between iC++ and control mice
(p < 0.01). Together, these activation and inactivation experi-
ments demonstrate the sleep-promoting function of CeA NTS
neurons.
In addition to bidirectional manipulation, we also measured
the endogenous sleep-wake activity of ChR2-tagged CeA
NTS neurons using optrode recording (Anikeeva et al., 2011;
Xu et al., 2015). High-frequency laser pulses (15 or 30 Hz, 5
or 10 ms per pulse, 16 pulses per train) were applied intermit-
tently, and single units exhibiting reliable laser-evoked spiking
at short latencies and low jitter were identified as NTS neurons
(Figures 4A and 4B). To quantify the relative firing rates of each
neuron in different brain states, we plotted its NREM-wake
modulation ((RNREM  Rwake)/(RNREM + Rwake), where R is the
mean firing rate within each state) versus REM-wake modula-
tion ((RREM  Rwake)/(RREM + Rwake)). Of the 23 identified NTS
neurons, the great majority fell in the upper right quadrant (Fig-
ure 4C), indicating that they are more active during NREM andNeuron 103, 1–12, July 17, 2019 3
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Figure 2. NTS Is a Marker for CeA Candidate Sleep Neurons
(A) Schematic of translating ribosome affinity purification (TRAP) for gene-expression profiling.
(B) TRAP sequencing result for LC- and PB-projecting CeA GABAergic neurons, with statistical significance plotted against fold enrichment in IP versus input
fraction. CeA tissues from 4–5 mice were pooled in each of the two experimental replicates. The highly enriched genes (indicated in red) include Rpl10a
(overexpressed by HSV, serving as a positive control for the gene profiling experiment),Bcar1,Nedd9, Efs,Gtf2i, Arhgap36,NFatc2, Scyl2, andOgt in addition to
the three peptides (Nts, Tac2, and Pdyn).
(C) Overlap between Nts and Tac2 (91% of Nts and 86% of Tac2), Nts and Pdyn (76% of Nts and 54% of Pdyn), and Nts and Gad1 (100% of Nts) in the posterior
CeA based on double FISH. Scale bars, 100 mm.
(D) Overlap between RV-EGFP and Nts in posterior CeA, for retrograde tracing from LC (59.2% ± 1.6% of EGFP neurons express NTS, n = 3 mice), PB
(67.2% ± 2.6%, n = 3 mice), and VTA (61.6% ± 2.8%, n = 3 mice). Scale bars, 100 mm.
(E) Overlap between RV-EGFP and PKCd (8.6% ± 1.2%, n = 3 mice) or enkephalin (PENK, 9.1% ± 0.9%, n = 3 mice) for retrograde tracing from LC, which is
significantly lower than the overlap with NTS (p = 0.001, t test). Scale bars, 100 mm.
See also Figure S2.
Please cite this article in press as: Ma et al., Sleep Regulation by Neurotensinergic Neurons in a Thalamo-Amygdala Circuit, Neuron (2019), https://
doi.org/10.1016/j.neuron.2019.05.015REM sleep than wakefulness (p = 0.04 for both NREM-wake
and REM-wake modulation, t test). Individually, 9 neurons
showed significantly higher rates during NREM sleep than
wakefulness (p < 0.01, Wilcoxon rank sum test), and only 2
were more active during wakefulness; 13 neurons showed
significantly higher firing rates during REM sleep than wakeful-
ness, and only 1 showed the opposite. In contrast, the uniden-
tified CeA neurons (n = 29) showed a much higher degree of
functional diversity, including many neurons that were more
active during wakefulness than sleep (Figure 4C, gray symbols).
Thus, the NTS subpopulation of CeA neurons are sleep active
as well as sleep promoting.4 Neuron 103, 1–12, July 17, 2019Identification of Glutamatergic Sleep Neurons in
Posterior Thalamus
Having established that CeA NTS neurons are GABAergic sleep-
promoting neurons, we next set out to identify their glutamater-
gic inputs; in principle, these upstream neurons could promote
NREM sleep by exciting CeA neurons, thus serving as additional
candidate sleep neurons (Figure 5A). RV-mediated retrograde
tracing from CeA NTS neurons followed by FISH-IHC of
Slc17a6 (encoding VGLUT2) and RV-EGFP revealed two regions
with strong glutamatergic inputs: the paraventricular nucleus of
the thalamus (PVT) (Figures S4A and S4B) (Penzo et al., 2015;
Ren et al., 2018; Zhu et al., 2018) and a posterior region of the
-200 -100 0 100 200 300
Time (s)
0
20
40
60
80
P
er
ce
nt
ag
e 
(%
)
NREM
Wake
REM
Fr
eq
 (H
z)
EMG
25
1
EEG
0
1
Fr
eq
 (H
z)
EMG
25
1
EEG
0
1
Time (s)
0   120 0.7
1
*
N     N
0   120 0
0.2
N     W
*
0   120 0
0.1
N     R
*
0
1
0
1
R     W R     R
* *0.6
1
0
0.5W     W W     N
Time (s)
Tr
an
si
tio
n 
P
ro
ba
bi
lit
y
NTSCeA-iC++
NTSCeA-ChR2
REMNREM Wake
0
1 R     W
0
1
R     R
0.6
1
0
0.5
W     W W     N
**
0
0.2
0   120 
N     W
*
0   120 0.7
1
N     N
*
0   120 0
0.1
N     R
*
A
B C
Tr
an
si
tio
n 
P
ro
ba
bi
lit
y
D
E F
60 s
2 
m
V
60 s
2 
m
V
-200 -100 0 100 200 300
Time (s)
0
20
40
60
80
P
er
ce
nt
ag
e 
(%
)
NREM
Wake
REM
REMNREM Wake
*
 Significant increase
 Significant decrease
*
Baseline
N
W R
 Significant increase
 Significant decrease
*
Baseline
*
N
W R
Figure 3. Optogenetic Activation and Inacti-
vation of CeA NTS Neurons Enhances and
Suppresses NREM Sleep, Respectively
(A) An example optogenetic activation experiment in
a NtsCre mouse with AAV-EF1a-DIO-hChR2-EYFP
injected into the posterior CeA. Shown are the EEG
spectrogram, EMG trace, and brain states (color
coded). Blue shading represents laser stimulation
(10 Hz, 120 s). Freq., frequency.
(B) Percentage of time in NREM, REM, or the wake
state before, during, and after laser stimulation,
averaged from 12 mice. Laser stimulation signifi-
cantly increased NREM sleep (p < 0.0001, boot-
strap) and decreased wakefulness (p < 0.0001) and
REM sleep (p < 0.001). Shading represents the 95%
confidence interval (CI; bootstrap), and the blue
stripe indicates the laser stimulation period.
(C) Effect of laser stimulation on transition proba-
bility between each pair of brain states. Each bar
represents transition probability within each 20-s
period (averaged across 3 consecutive 20-s bins
within each 60 s). Error bar represents the 95% CI.
Dashed line represents the baseline transition
probability. N, NREM; R, REM; W, wake. W/R and
R/N transitions are omitted, because they were
rarely detected with or without laser stimulation.
Magenta and cyan asterisk (*) indicates significant
increase and decrease in transition probability
during laser stimulation compared to baseline
(p < 0.05, bootstrap). The diagram summarizes
transitions that are significantly increased
(magenta), decreased (cyan), or unaffected (black)
by laser stimulation.
(D–F) Similar to (A)–(C), but for iC++-mediated op-
togenetic inactivation of NTS neurons (constant
light, 120 s) in the posterior CeA (p < 0.0001 for a
decrease in NREM and p < 0.01 and 0.001 for in-
creases in REM and wake, n = 7 mice). (D) Similar to
(A), (E) similar to (B), and (F) similar to (C).
See also Figure S3.
Please cite this article in press as: Ma et al., Sleep Regulation by Neurotensinergic Neurons in a Thalamo-Amygdala Circuit, Neuron (2019), https://
doi.org/10.1016/j.neuron.2019.05.015thalamus (Figures 5B, 5C, and 5F). Interestingly, in both regions,
a large fraction of RV-labeled neurons also expressed NTS (Fig-
ures 5D–5F, S4C, and S4D).
To test the roles of these thalamic NTS neurons in sleep regu-
lation, we applied bidirectional optogenetic manipulation. In the
posterior region of the thalamus (herein referred to as ‘‘posterior
thalamus,’’ pTh), ChR2-mediated activation of NTS neurons
caused a significant increase in NREM sleep and decrease in
wakefulness (Figures 5G, S5A, and S5B), whereas iC++-medi-
ated inactivation of these neurons had the opposite effects (Fig-
ures 5H and S5C). In contrast, activation of PVT NTS neurons did
not promote sleep (Figure S4E) (Ren et al., 2018). Thus, amongthe glutamatergic candidate sleep neurons
innervating CeA neurons, the NTS popula-
tion in the posterior thalamus is confirmed
as NREM-promoting neurons. To assess
whether the NTS neurons in the posterior
thalamus are naturally active during sleep,
we performed double FISH of Nts and the
activity marker gene Fos. Compared to
control mice with undisturbed sleep-wakebehavior, rebound sleep (RS) following deprivation strongly
increased Fos expression in NTS neurons (Figure S5D), indi-
cating that they are sleep active. Interestingly, Fos expression
following sleep deprivation (SD) was also higher than the control
though lower than following RS, suggesting that posterior
thalamic NTS neurons are activated by sleep pressure in addition
to sleep.
BothNTSPeptide andClassical Transmitters Contribute
to NREM Sleep
The fact that both the CeA GABAergic and posterior thalamic
glutamatergic NREM-promoting neurons express NTS raisesNeuron 103, 1–12, July 17, 2019 5
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Please cite this article in press as: Ma et al., Sleep Regulation by Neurotensinergic Neurons in a Thalamo-Amygdala Circuit, Neuron (2019), https://
doi.org/10.1016/j.neuron.2019.05.015the possibility that the peptide itself plays a role in NREM sleep
generation. To test this possibility, we usedCRISPR/Cas9-medi-
ated genome editing to knock down NTS expression in each
population. In NtsCre mice crossed with Cre-inducible Cas9
knockin mice (Platt et al., 2014), we injected an AAV vector en-
coding both Nts-targeting single guide RNA (sgRNA) and Cre-
inducible ChR2-mCherry into the CeA to express ChR2 in
NTS-knockdown cells (Figure 6A). Compared to the control
sgRNA targeting lacZ, Nts-targeting sgRNA caused an 80%
reduction of NTS expression in the infected neurons (Figures
6B and S6A). Optogenetic experiments showed that NTS knock-
down greatly reduced the magnitude of NREM increase induced
by ChR2-mediated activation of CeA NTS neurons (Figures 6C
and 6D). This reduction was not due to a decreased firing of
these neurons evoked by ChR2 activation (Figures S6B and
S6C), indicating that the NTS peptide contributes significantly
to the promotion of NREM sleep. We next performed CRISPR/
Cas9-mediated knockdown of the vesicular GABA transporter
(VGAT; encoded by Slc32a1) (Figures 6A and S6E), which plays
a crucial role in GABAergic synaptic transmission (Kim and Ker-
schensteiner, 2017; Rau and Hentges, 2017). This also greatly
reduced the NREM increase induced by optogenetic activation
(Figures 6C and 6D), indicating that both GABA and NTS
signaling are important for sleep regulation by CeANTS neurons.6 Neuron 103, 1–12, July 17, 2019In addition to the NREM increase induced by optogenetic activa-
tion, NTS and VGAT knockdown also caused small but signifi-
cant reductions of baseline NREM sleep (Figures S7A and S7B).
We then tested the role of NTS signaling in posterior thalamic
glutamatergic neurons using CRISPR/Cas9-mediated knock-
down (Figures 7A, 7B, and S6D). Compared to the control
lacZ-targeting sgRNA, Nts-targeting sgRNA largely eliminated
the NREM increase induced by optogenetic activation of poste-
rior thalamic NTS neurons (Figures 7C and 7D) in addition to
reducing baseline sleep (Figures S7C). Similar effects were
observed with the knockdown of VGLUT2 (Figures 7C, 7D,
S6F, and S7D), which is crucial for glutamatergic synaptic
transmission (Schweizer et al., 2014; Shen et al., 2018). These
results indicate that sleep regulation by thalamic NTS neurons
also depends on both the classical transmitter and the NTS
neuropeptide.
DISCUSSION
Using RV-mediated retrograde tracing to label GABAergic neu-
rons innervating wake-promoting neurons and glutamatergic
neurons innervating sleep-promoting neurons, we have identi-
fied multiple groups of candidate sleep neurons. Bidirectional
optogenetic manipulation validated NTS neurons in both the
...
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See also Figures S4 and S5.
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doi.org/10.1016/j.neuron.2019.05.015posterior CeA and the posterior thalamus as NREM-promoting
neurons. While the current study focused on CeA GABAergic
neurons and their glutamatergic inputs, our initial screening
has identified additional candidate sleep neurons (Figure 1B),
some of which remain to be functionally tested. The three-
step approach used in this study—anatomical screening, marker
identification, and functional validation (Figures 1, 2, 3, 4,and 5)—can also be expanded to more wake- or sleep-promot-
ing populations to identify additional neurons in the sleep-control
network.
The CeA has been implicated in multiple functions, including
the control of fear, anxiety, feeding, and other appetitive behav-
iors (Cai et al., 2014; Carter et al., 2013; Ciocchi et al., 2010;
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jected into NtsCre mice crossed with Cre-inducible
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(B) Nts-targeting sgRNA caused a strong reduction
of NTS expression compared to control lacZ-tar-
geting sgRNA. Left: fluorescence images of CeAwith
ChR2-mCherry expression (red) and immunohisto-
chemistry of NTS (green). Right: percentage of
mCherry-expressing neurons with clear NTS
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Scale bars represent 100 mm (low magnification) or
20 mm (high magnification).
(C) Effects of laser stimulation on brain states in lacZ
control (left, n = 8 mice, p < 0.0001, < 0.0001, and =
0.24 for NREM, wake, and REM states), NTS
knockdown (middle, n = 8, p = 0.026, 0.015, and
0.33), and VGAT knockdown (right, n = 8, p = 0.004,
0.0001, and 0.29) mice. Shading represents 95% CI.
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(D) Changes in the percentage of each brain state
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120 s during laser stimulation) induced by ChR2-
mediated activation of CeA NTS neurons in control,
NTS knockdown, and VGAT knockdown mice. Error
bars represent SEM. The magnitude of NREM
increase and wake decrease induced by laser stim-
ulation was significantly different between lacZ
control and NTS knockdown and between control
and VGAT knockdown groups. *p < 0.05; **p < 0.01,
t test.
See also Figures S6 and S7.
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See also Figures S6 and S7.
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McCall et al., 2015; Viviani et al., 2011) as well as REM sleep
(Sanford et al., 2002) and cataplexy (Mahoney et al., 2017).
Our study demonstrates its causal role in promoting NREM
sleep. There are multiple cell types in the CeA, expressing
different neuropeptides, and they are likely involved in different
functions. A recent study showed the involvement of cortico-
tropin-releasing hormone (Crh)+Tac2+Nts+ CeL neurons in
appetitive behaviors in food- or water-deprived mice (Kim
et al., 2017). In our experiments in mice with free access to
food and water, NTS neuron activation and inactivation pro-
moted and suppressed NREM sleep, respectively (Figure 3).
These different effects may be related to the different behav-
ioral contexts or different CeL subregions targeted in the two
studies. In future studies, it would be interesting to explore
whether and how CeA neurons mediate the interaction between
appetitive behaviors (e.g., feeding and drinking), emotional pro-
cessing, and sleep (Krause et al., 2017; Yamashita and Yama-
naka, 2017). Furthermore, a significant fraction of the CeA neu-
rons innervating wake-promoting populations are non-NTS
cells (Figure 2D), which may also contribute to sleep regulation.
These may include PDYN- or TAC2-positive but NTS-negative
neurons or neurons expressing the non-peptide markers
identified in the gene-profiling experiment (Figure 2B). Both
the genetic identity and functional importance of these neurons
await future investigation.
The sleep-promoting effect of CeA NTS neurons is likely medi-
ated in part by their broad GABAergic inhibition of multiple wake-
promoting populations (Brown et al., 2012; Saper et al., 2010;
Scammell et al., 2017; Weber and Dan, 2016) (Figure S2). Up-
stream to these CeA neurons, a major population of glutamater-
gic sleep neurons was found in the posterior thalamus (Figure 5).
While their excitatory innervation of the CeA neurons is likely to
contribute to the sleep-promoting effect, these thalamic neurons
also send axon projections to other brain regions, some of which
may also participate in sleep regulation.
Apart from the traditional neurotransmitters, glutamate and
GABA, the posterior thalamic and CeA neurons both contain
neuropeptides, and NTS knockdown in each population greatly
reduced their sleep-promoting effect (Figures 6 and 7). This is
consistent with the negative impact of NTS receptor 1 knockout
on sleep (Fitzpatrick et al., 2012), indicating that NTS signaling
plays an important role in sleep generation. Interestingly, the
NTS peptide is also known to lower the blood pressure and
body temperature (Bissette et al., 1982; Carraway and Leeman,
1973), processes naturally associated with NREM sleep (Alfo¨ldi
et al., 1990; Jafari, 2017; Silvani and Dampney, 2013). This
suggests that the NTS-releasing neurons could serve to coordi-
nate NREM sleep generation and the associated autonomic
regulation.
Like many other neuropeptides, NTS may act through local
synaptic transmission and/or diffuse volume transmission (van
den Pol, 2012). In future studies, it would be important to deter-
mine whether the peptides released by the CeA and pTh act on
the same neurons that receive the GABAergic and glutamatergic
innervation, respectively. Through volume transmission, it is
even possible that NTS released by different brain regions acts
on common neuronal targets. In addition to the CeA and poste-10 Neuron 103, 1–12, July 17, 2019rior thalamus, NTS-expressing neurons are distributed in multi-
ple other brain regions (2011 Allen Institute for Cell Science, Allen
Mouse Brain Atlas, available at http://mouse.brain-map.org/
experiment/show/73788032), many of which are closely associ-
ated with the central autonomic network. Our finding that the two
populations along the thalamo-amygdala pathway both promote
NREM sleep raises the possibility that NTS may serve as a com-
mon marker for multiple neuronal groups in the sleep-control
network.
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Animals
The following mice were obtained from Jackson Laboratory (Jackson stock number in parenthesis): Slc17a6Cre (016963), ChatCre
(006410), HdcCre (021198), PvalbCre (008069), NtsCre (017525), and Rosa26-floxed-STOP-Cas9 (024857). ThCre mice were obtained
from the European Mouse Mutant Archive (EM:00254). Rabies tracing, gene profiling, optogenetic manipulation, and optrode
recording experiments were performed on adult mice (> 2 months) of both genders. Slice recordings were performed on mice older
than 1month of both genders. Mice were housed in 12 h light-dark cycle (lights on 07:00 and off at 19:00) with free access to food and
water. All procedures were approved by Animal Care and Use Committees of the University of California, Berkeley and were done in
accordance with federal regulations and guidelines on animal experimentation.
METHOD DETAILS
Virus preparation
AAV2-EF1a-DIO-hChR2-eYFP, AAV2-EF1a-DIO-iC++-eYFP, AAV2-EF1a-DIO-eYFPwere obtained from the University of North Car-
olina (UNC) vector core. For RV-mediated circuit tracing, pCAG-FLEx-TC and pCAG-FLEx-RG constructs were generous gifts from
Liqun Luo, and AAV2 viruses were packaged in-house according to previously described protocols (Hauswirth et al., 2000). HSV-
hEF1a-LoxSTOPLox (LSL)-FlagHA-L10a was obtained from MIT viral core. G-Deleted rabies-eGFP were purchased from Gene
Transfer Targeting and Therapeutics Core of Salk Institute, amplified in B7GG cells, pseudotyped with BHK-EnvA cells, and titered
with HEK293-TVA cells (Osakada and Callaway, 2013).
Surgery
Adult mice (6-12 weeks old) were anesthetized with 1.5%–2% isoflurane and placed on a stereotaxic frame. Heat pad was used to
keep the body temperature stable during the whole procedure. Eye ointment was applied to keep the eyes from drying. After shaving
hairs and asepsis with Betadine and medical alcohol, an incision was made to the skin to expose the skull.
For virus injection, a craniotomy was made on top of the target region, and 0.1-0.3 ml virus was injected into the target region using
Nanoject II (Drummond Scientific) via a micro pipette. For optogenetic activation/inhibition experiments, AAV2-EF1a-DIO-hChR2-
eYFP, AAV2-EF1a-DIO-iC++-eYFP, AAV2-EF1a-DIO-eYFP, or AAV2-U6-sgRNA (lacZ, Nts, Slc32a1, or Slc17a6)-pCbh-DIO-
ChR2-mCherry was injected into the posterior CeA, posterior thalamus or PVT of NtsCre or NtsCre;Rosa26-floxed-STOP-Cas9
mice. For rabies tracing, a mixture of AAV2-CAG-FLEx-TVA-mCherry and AAV2-CAG-FLEx-RG was injected into the target region
of the corresponding Cre mice. Two to three weeks later, EnvA-pseudotyped, glycoprotein (RG)-deleted, and eGFP-expressing
rabies viral particles (RV) were injected into the same region, and mice were sacrificed 5 – 6 days later.
Stereotaxic coordinates for injections:
LC: AP 5.4 mm, ML 0.9 mm, DV 3.7 mm
PB: AP 5.2 mm, ML 1.2 mm, DV 3.2 mm
PPT: AP 4.7 mm, ML 1.2 mm, DV 3.5 mm
TMN: AP 2.5 mm, ML 0.9 mm, DV 5.3 mm
BF: AP 0.1 mm, ML 1.2 mm, DV 5.6 mm
VTA: AP 3.3 mm, ML 0.4 mm, DV 4.3 mm
Posterior CeA: AP 1.6 to 1.7 mm, ML 3.0 mm, DV 4.5 mm
Posterior thalamus: AP 3.3 – 3.4 mm, ML 1.8 mm, DV 3.1 3.2 mm
PVT: AP 0.4 mm, ML 0 mm, DV 3.6 mm
Optic fibers were implanted into the target region twoweeks after viral injection. Electroencephalogram (EEG) and electromyogram
(EMG) implants were placed in the same surgery as for optic fibers. To implant EEG and EMG recording electrodes, two stainless
steel screws were inserted into the left and right skull 3 mm from midline and 3.5 mm posterior to the bregma (adjusted slightly if
an optic fiber is placed near these locations), a reference screw was inserted into the skull on top of the right cerebellum. Two
EMG electrodes were inserted into the neck musculature. Insulated leads from the EEG and EMG electrodes were soldered to a
pin header, which was secured to the skull using dental cement. Dental cement was applied to cover the exposed skull completely
and to secure the implants for EEG and EMG recordings to the screws. After surgery, mice were allowed to recover for 1-2 weeks
before experiments.
Polysomnographic recordings
Behavioral experiments were carried out in home cages placed in sound-attenuating boxes between 11:00 am and 6:00 pm (light
phase) and between 9 pm and 1 am (dark phase). EEG and EMG electrodes were connected to flexible recording cables via a
mini-connector. Recordings started after 20-30 min of habituation. The signals were recorded with a TDT RZ5 amplifier, filtered
(1-750 Hz) and digitized at 1,500 Hz. Spectral analysis was carried out using fast Fourier transform (FFT), and the brain state forNeuron 103, 1–12.e1–e7, July 17, 2019 e3
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doi.org/10.1016/j.neuron.2019.05.015each 5 s epoch was classified into NREM, REM and wake states (wake: desynchronized EEG and high EMG activity, NREM: syn-
chronized EEG with high-amplitude, low-frequency (0.5-4 Hz) activity and low EMG activity, REM: high power at theta frequencies
(6-9 Hz) and low EMG activity). The classification was made using custom-written MATLAB software.
Sleep deprivation and rebound
Sleep deprivation started at 7 am. Mice were kept awake by introducing novel objects or tapping lightly on the cages. To reduce the
possibility of stress, mice were never touched directly. After 6 hr of deprivation, sleep-deprived mice were allowed rebound sleep in
their home cages for 2-3 hr before sacrificed.
Optogenetic manipulation
Each optic fiber (200 mmdiameter; ThorLabs) was attached through an FC/PC adaptor to a 473-nm blue laser diode (Shanghai laser),
and light pulses were generated through the TDT system. Optogenetic activation experiments (in ChR2- or eYFP-expressing mice)
were conducted unilaterally, and optogenetic inhibition experiments (in iC++- or eYFP-expressing mice) were conducted bilaterally.
Fiber optic cables were connected 20-30 min before the experiments for habituation. Light pulses (10 ms per pulse, 10 Hz, 120 s,
3-6 mW) or constant light (120 s, 3-6 mW) were applied for optogenetic activation and inactivation experiments, respectively. In
each optogenetic manipulation experiment, inter-stimulation interval was chosen randomly from a uniform distribution between 7
and 16 min. Each experimental session lasted for 3 h, and each animal was tested for 5-8 sessions. Mice showing no ChR2-eYFP
expression in CeA or with misplaced optic fiber (> 500 mm from the NTS neuron cluster) were excluded from behavioral analysis.
Optrode recording
Each optrode consisted of an optic fiber (200 mm in diameter) glued together with 6 pairs of stereotrodes, with two FeNiCr wires (Sta-
blohm 675, California FineWire) twisted together and electroplated to an impedance of200 kU using a custom-built plating device.
The optrode was attached to a driver to allow vertical movement of the optrode assembly. Wires to record cortical EEG and EMG
from neckmusculatures were also attached for simultaneous recordings. A TDTRZ5 amplifier was used for all the recordings, signals
were filtered (0.3-8 kHz) and digitized at 25 kHz.
Spikes were sorted offline based on the waveform energy and the first three principal components of the spike waveform on each
stereotrode channel. Single units were identified automatically using the software KlustaKwik (http://klustakwik.sourceforge.net).
The quality of each unit was assessed by the presence of a refractory period and quantified using isolation distance and L-ratio. Units
with an isolation distance < 20 and L-ratio > 0.1 were discarded.
To identify ChR2-tagged neurons, laser pulse trains (15 and 30 Hz with duration of 1 and 0.5 s, respectively) were delivered every
minute. A unit was identified as ChR2 expressing if spikes were evoked by laser pulses with high reliability (> 50% for all units in our
sample), short first-spike latency (< 7 ms for 22/23 units, 9 ms for 1 unit), low jitter (< 3 ms for all units in our sample), and the wave-
forms of the laser-evoked and spontaneous spikes were highly similar (correlation coefficient > 97%). To calculate the average firing
rate of each unit in each brain state, spikes during the laser pulse trains were excluded.
Immunohistochemistry and immunocytochemistry
For immunohistochemistry, mice were deeply anesthetized and transcardially perfused using PBS followed by 4% paraformalde-
hyde in PBS. Brains were post-fixed in 4% paraformaldehyde for 24 - 48 h and stored in 30% sucrose in PBS solution for 48 h for
cryoprotection. Brains were embedded and mounted with Tissue-Tek OCT compound (Sakura finetek) and 40 mm sections were
cut using a cryostat (Leica). For c-Fos induction, light pulses (10 ms per pulse, 10 Hz, 120 s, 3-6 mW, 2 min interval) were given
for 0.5 h before sacrificing the animal. For c-Fos staining, brain slices were washed using PBS and subjected to heat-induced antigen
retrieval with 0.1 M citric acid (pH 6.0) at 95C for 5 min. Slices were then washed with PBS, permeabilized using PBST (0.3% Triton
X-100 in PBS) for 30 min and incubated with blocking solution (5% normal goat serum or normal donkey serum in PBST) for 1 h fol-
lowed by primary antibody incubation overnight at 4 C. The following primary antibodies were used: rat anti-mCherry (1:1000,
M11217, Thermo Fisher Scientific) and rabbit anti-c-Fos (1:5000, 226003, Synaptic System). The next day, after sufficient washing
in PBS, sections were incubated in proper fluorescently conjugated secondary antibodies (1:500, Invitrogen or Jackson Immuno
Research) for 2 h at room temperature. Finally, sections were counterstained with 4’,6-diamidino-2-phenylindole dihydrochloride
(DAPI; Sigma-Aldrich) and mounted on slides with VECTASHIELD Antifade Mounting Medium (Vector Laboratories, H-1000).
Fluorescence images were taken with a confocal microscope (LSM 710 AxioObserver Inverted 34-Channel Confocal, Zeiss), a fluo-
rescence microscope (Keyence BZX-710), and Nanozoomer (Hamamatsu).
For NTS staining, Alexa Fluor 488 Tyramide SuperBoost Kit (B40922, Thermo Fisher Scientific) was used. Briefly, floating brain
slices were treated with 3%hydrogen peroxide solution for 15min to quench the endogenous peroxidase activity and then subjected
to heat-induced antigen retrieval as described above. After wash with PBS, slices were incubated in blocking buffer for 1 h. Rat anti-
mCherry antibodies together with rabbit anti-NTS (1:5000, 20072, Immuno Star) were applied for at least 18 h at 4C. Afterward, sec-
tions were washed three times with PBS, 10 min each. Poly-HRP-conjugated goat anti-rabbit secondary antibody was applied
together with Alexa Fluor 594 goat anti-rat IgG to the slices for 2 h at room temperature. Slices were washed with PBS three times,
10 min each. Tyramide working solution was prepared according to the manufacturer’s instructions, and colors were developed with
Alexa Fluor 488 Tyramide for 10min. Reaction stop reagent was applied, and sliceswere counterstainedwith DAPI andmountedwithe4 Neuron 103, 1–12.e1–e7, July 17, 2019
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doi.org/10.1016/j.neuron.2019.05.015antifade mounting medium. Images were taken with LSM 710 confocal microscope. Cell counting was done with custom-written
MATLAB software. Only cells with clear NTS signal were considered as positive. Control group and NTS knockdown group were
stained, imaged, and counted in parallel to maximize accuracy of comparison between them.
For immunocytochemistry, 72 h after transfection, cells seeded on PDL-coated (100 mg/mL) coverslips were quickly washed with
PBS, fixed with 4% PFA for 20 min, followed by washes with PBS three times, 5 min each. Cells were then incubated in PBS sup-
plemented with 5% normal goat serum and 0.25% Triton X-100 (blocking solution) for 1 h before incubated in primary antibodies
(mouse anti-FLAG, 1:1000, Sigma) diluted in blocking solution at 4C overnight. Samples were washed thoroughly, incubated in
Alexa Fluor 488 goat anti-mouse antibodies (1: 500, Invitrogen or Jackson Immuno Research) for 1 h at room temperature. For coun-
terstain of the nuclei, samples were incubated in 1 mg/mL DAPI for 10 min before being mounted on slides with VECTASHIELD Anti-
fade Mounting Medium. Fluorescence images were taken using LSM 710 confocal microscope. FLAG fluorescence intensity was
measured with ImageJ software.
Fluorescence in situ hybridization (FISH)
FISH was performed with twomethods. First, for double staining of Nts and Tac2,Nts and Pdyn,Nts andGad1,Nts and Slc17a6,Nts
and Cre, Nts and Fos, Nts and Gbx2, NTS and Tcf7l2, Nts and RV-eGFP for PB and VTA tracing, as well as Nts and RV-eGFP in PVT,
double FISHwas performed using RNAscope assays according to the manufacturer’s instructions (Advanced cell Diagnostics). Sec-
ond, for double staining ofGad1/2 and RV-eGFP, Slc17a6 and RV-eGFP, Prkcd and RV-eGFP, Penk and RV-eGFP as well asNts and
RV-eGFP in the posterior thalamic region, FISH-IHC procedure was used. The following primer sequences were used for cloning of
Gad1, Gad2, Slc17a6, Nts, Prkcd, and Penk probes (50 > 30) (see also Table S1):
Gad1 (sense/anti-sense):
TGTGCCCAAACTGGTCCT / TGGCCGATGATTCTGGTT;
Gad2 (sense/anti-sense):
TCTTTTCTCCTGGTGGCG / TTGAGAGGCGGCTCATTC;
Slc17a6 (sense/anti-sense):
CCAAATCTTACGGTGCTACCTC / TAGCCATCTTTCCTGTTCCACT;
Nts (sense/anti-sense):
ATGAGAGGAATGAATCTCCAGC / TCAGTAGTAGTAGGAACCCCTCT;
Prkcd (sense/anti-sense):
TTCCTGCGCATCTCCTTC / TGCATTGCCTGCATTTGT;
Penk (sense/anti-sense):
CCTGAGGCTTTGCACCTGG / TCCCAGTAGCTCTTTCAGCAG;
To make FISH probes, DNA fragments were amplified using PCR from mouse whole brain cDNA (Zyagen). A T3 RNA polymerase
recognition site was added to the 30 end of the PCR product. The PCR product was purified using a PCR purification kit (QIAGEN).
1 mg of DNA was used for in vitro transcription by using digoxigenin (DIG) RNA labeling mix (Roche) and T3 RNA polymerase. After
DNase I treatment for 30 min at 37C, the RNA probe was purified using probeQuant G-50 Columns (GE Healthcare). 50 mm sections
were floated off the slide into 24-well plate, treated with 2%hydrogen peroxide for 15min, fixed for 15min in 4%paraformaldehyde in
PBS at room temperature, pretreated with proteinase K (10 mg/ml) in 10 mM Tris-Cl, pH 7.4, 1 mM EDTA buffer for 15 min at 37C,
fixed again with 4% paraformaldehyde in PBS for 10 min and rinsed with PBS. The sections were incubated with 0.25% acetic an-
hydride in 0.1 M triethanolamine, pH 8.0, for 15 min and washed with PBS. Pretreated sections were then incubated for 16-20 h at
53-58C, in a hybridization buffer (50% formamide, 10mM Tris-Cl pH 8.0, 200 mg/ml tRNA, 10% Dextran Sulfate, 1x Denhalt’s
solution, 600mM NaCl, 0.25% SDS) containing antisense riboprobes. After hybridization, the sections were washed, first with 2 3
SSC-50% formamide, then with 2 3 SSC, for 15 min at 58-63C, treated with RNase A (10 mg/ml) for 30 min at 37C, and finally
washed with 2x SSC and 0.2 3 SSC twice each for 15 min at 37C. After blocking for 1hr with 5% normal goat serum in PBS with
0.1% Triton X-100 (PBT), sections were incubated with alkaline phosphatase-conjugated anti-DIG antibody (1:1000,
11093274910, Roche Applied Science) and chicken anti-GFP antibodies (1:500, GFP-1020, Aves Labs) overnight at 4C. After
washing with PBT three times for 20 min, sections were incubated with Alexa Fluor 488 conjugated donkey anti-chicken antibodies
(Jackson Immuno Research) for an additional 2h, and washed with PBS three times for 10 min. Probe positive cells were then de-
tected by Fast Red TR/Naphthol AS-MX Tablets (F4523, Sigma-Aldrich). Finally, the sections were treated with PBS containing
DAPI and mounted with cover glass.
Translating ribosome affinity purification (TRAP)
TRAP experiment was performed as previously described (Heiman et al., 2014; Nectow et al., 2015). Briefly, micewere sacrificed and
the CeA was rapidly dissected on ice with a dissection buffer (1xHBSS, 2.5 mM HEPES [pH 7.4], 4 mM NaHCO3, 35mM Glucose,
100 mg/ml Cycloheximide). Tissues from 4-5 mice were then pooled, homogenized in the homogenization buffer (20 mM HEPES
[pH 7.4], 150 mM KCl, 10 mM MgCl2, 0.5 mM DTT, 80 U/ml RNasin, 40 U/ml Superasin, 100 mg/ml cycloheximide and protease).
Homogenates were transferred to a microcentrifuge tube and clarified at 2,000xg for 10 min at 4C. The supernatant was transferredNeuron 103, 1–12.e1–e7, July 17, 2019 e5
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(DHPC, 300mM) were added to the supernatant. This solution was mixed and then clarified at 20,000xg for 10 min at 4C. The result-
ing supernatant was transferred to a new tube. This supernatant served as the input. A small amount (50 ml) was taken and added to a
new tube containing 100 mL of lysis buffer from Absolutely RNANanoprep kit (Agilent) for future input RNA purification. The rest of the
supernatant were used for immunoprecipitation with FLAG and HA antibodies.
Immunoprecipitation was performed with an anti-FLAG (F1804, Sigma) and anti-HA (#3724, Cell Signaling Technology) antibody
loaded ProteinA Dynabeads (10002D, Thermo Fisher Scientific). The samples and beads were incubated for 1h at 4C. The beads
were washed four times using 0.35M KCl Wash buffer (20 mM HEPES [pH 7.4], 350 mM KCl, 10 mM MgCl2, 0.5 mM DTT,
1% NP40, 40 U/ml RNasin, and 100 mg/ml cycloheximide). After the final wash the RNA was eluted by addition of lysis buffer
(100 mL) to the beads. Beads were removed with a magnet. Both the input and IP RNAs are purified with Absolutely RNA Nanoprep
kit (Agilent) and analyzedwith an Agilent 2100 Bioanalyzer. cDNAswere generated and amplifiedwith SMART-Seq v4Ultra Low Input
RNA Kit. cDNA libraries for RNA-seq were prepared with Illumina Nextera Library Prep Kit and analyzed on an Illumina HiSeq 4000.
RNA-seq data were analyzed with RSEM (RNA-Seq by Expectation-Maximization) (Li and Dewey, 2011). Further gene expression
analysis was done with DESeq2 software. Transcripts with TPM ((Transcripts Per Kilobase Million) > 1 were used for analysis.
CRISPR/Cas9-mediated gene knockdown
For Cas9 target selection, the 20-nt target sequencewas selected to precede a 50-NGGprotospacer-adjacent motif (PAM) sequence.
Sequences of Nts exon 3, Slc32a1 exon 2, and Slc17a6 exon 2 (200 bp) were submitted to the CRISPR design tool (http://zlab.bio/
guide-design-resources) for the selection of sgRNA sequences. sgRNAs with quality scoreS 95 were chosen. Control sgRNA was
designed to target the lacZ gene from E. Coli (Sequence adopted from Addgene plasmid #60228). Guide oligos were synthesized by
IDT (Integrated DNA Technologies), and annealed as described in the CRISPR-Cas9 Mouse Toolbox (https://www.addgene.org/
crispr/zhang/). AAV-U6-sgRNA(backbone)-pCBh-Cre-WPRE-hGHpA construct was obtained from Addgene (#60229), andmodified
by replacing Cre with a DIO-ChR2-mcherry cassette. sgRNAs were cloned to the modified construct according to the CRISPR-Cas9
mouse Toolbox. AAV2 viruses were packaged according to previously described procedures (Hauswirth et al., 2000).
For in vitro efficiency test, NTS-FLAG, VGAT-FLAG, and VGLUT2-FLAG expressing plasmid were obtained fromOriGene Technol-
ogies (MR226576, MR208431, MR209115). Cas9-expressing 368T1mouse cell line was generous gift from Lin He (UCBerkeley). 13
105 368T1 cells were seeded on PDL-coated (100 mg/ml) coverslips in each well of 12-well plate in DMEM supplemented with 10%
Fetal Bovine Serum (FBS). 24 h later, pU6-sgRNA(backbone)-pCBh-Cre-WPRE-hGHpA, pCMV6-NTS-FLAG or pCMV6-VGAT-FLAG
or pCMV6-VGLUT2-FLAG, and Nts-targeting, Slc32a1-targeting, Slc17a6-targeting or lacZ-targeting sgRNA expressing plasmids
(1 mg of each plasmid for every well) were co-transfected into Cas9-expressiong 368T1 cells with Lipofectamine 2000 Transfection
Reagent according to manufacturer’s instructions. 72 h after transfection, cells were fixed and stained with FLAG antibodies as
described above.
Slice recording
AAV DJ-EF1a-DIO-ChR2-eYFP or AAV DJ-U6-sgRNA (targeting lacZ or Nts)-pCbh-DIO-ChR2-mCherry (0.3 ml) was injected into the
CeA of NtsCre or NtsCre;Rosa26-floxed-STOP-Cas9 mice. Acute slices were made 2 weeks after injection. The animal was deeply
anaesthetized with 5% isoflurane. After decapitation, the brain was dissected rapidly and placed in ice-cold oxygenated HEPES buff-
ered artificial cerebrospinal fluid (ACSF; in mM: 92 NaCl, 2.5 KCl, 1.2 NaH2PO4, 30 NaHCO3, 20 HEPES, 25 glucose, 5 sodium ascor-
bate, 2 thiourea, 3 sodium pyruvate, 10MgSO4, 0.5 CaCl2, and 12 NAC, at pH 7.4, adjusted with 10MNaOH), and coronal sections of
the LC, PB, or VTA were made with a vibratome (Leica). Slices (250 mm thick) were recovered in oxygenated NMDG (N-Methyl-D-
glucamine)-HEPES solution (in mM: 93 NMDG, 2.5 KCl, 1.2 NaH2PO4, 30 NaHCO3, 20 HEPES, 25 glucose, 5 sodium ascorbate, 2
thiourea, 3 sodium pyruvate, 10 MgSO4, 0.5 CaCl2 and 12 NAC, at pH 7.4, adjusted with HCl) at 32
C for 10 min and then maintained
in an incubation chamber with oxygenated standard ACSF (in mM: 125 NaCl, 3 KCl, 2 CaCl2, 2 MgSO4, 1.25 NaH2PO4, 1.3 sodium
ascorbate, 0.6 sodium pyruvate, 26 NaHCO3, 10 glucose and 10 NAC, at pH 7.4, adjusted by 10 M NaOH) at 25
C for at least 1 h
before recording. All chemicals were from Sigma.
Whole-cell recordings were made at 30 C in oxygenated solution (in mM: 125 NaCl, 4 KCl, 2 CaCl2, 1 MgSO4, 1.25 NaH2PO4, 1.3
sodium ascorbate, 0.6 sodium pyruvate, 26 NaHCO3 and 10 glucose, at pH 7.4). Inhibitory postsynaptic currents (IPSCs) were re-
corded using a cesium-based internal solution (in mM: 136 CsMeSO4, 7 CsCl, 10 HEPES, 0.5 EGTA, 4 MgCl2, 4 Na2ATP, 0.4 NaGTP,
5 QX-314, at pH 7.3, adjusted with CsOH, 290–300 mOsm). Light-evoked responses of ChR2-expressing CeA neurons were re-
corded with a potassium-based internal solution (in mM: 135 potassium gluconate, 5 KCl, 10 HEPES, 0.3 EGTA, 4 MgATP, 0.3
NaGTP, and 10 sodium phosphocreatine, at pH 7.3, 290-300 mOsm). The resistance of the patch pipette was 3-5 MU. The cells
were excluded if the series resistance exceeded 40 MU or varied by more than 20% during the recording period. To activate
ChR2, we used a mercury arc lamp (Olympus) coupled to the epifluorescence light path and bandpass filtered at 450-490 nm
(Semrock), gated by an electromagnetic shutter (Uniblitz). A blue light pulse (5 - 10 ms) was delivered through a 40 3 0.8 numerical
aperture water immersion lens (Olympus) at a power of 1-2 mW. Data were recorded with a Multiclamp 700B amplifier (Axon instru-
ments) filtered at 2 kHz and digitized with a Digidata 1440A (Axon instruments) at 4 kHz. Recordings were analyzed using Clampfit
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At the end of each recording, cytoplasm was aspirated into the patch pipette, expelled into a PCR tube as described previously
(Chung et al., 2017; Xu et al., 2015). The single cell RT-PCR protocol was designed to detect the presence of mRNAs coding
Slc17a6, Gad2, Th, Gapdh. First, a cDNA library of the transcriptome of the single cell was generated using the SuperScript III kit
(Invitrogen, 18080-051) according to the manufacturer’s protocol. Second, multiplex PCR amplification was performed with gene-
specificmultiplex primer using Accuprime Taq polymerase (12339-024, Invitrogen). Finally, nested PCRwas performed using GoTaq
Green Master Mix (M7122, Promega) with nested primers for each gene. Amplification products were visualized via electrophoresis
using 1.2% agarose gel.
Primers (50 > 30) for single-cell RT–PCR were as follows (see also Table S2).
Gapdh (sense/anti-sense):
Multiplex (572bp), ACTCCACTCACGGCAAATTC / CACATTGGGGGTAG GAACAC;
Nested (331 bp), AGCTTGTCATCAACGGGAAG / GTCATGAGCCCTTC CACAAT;
Gad2 (sense/anti-sense):
Multiplex (531 bp), CAGCCTTAGGGATTGGAACA / ACCCAGTAGTCCCCTTTGCT;
Nested (266 bp), GTTCCTTTCCTGGTGAGTGC / TGCATCAGTCCCTCCTCTCT;
Slc17a6 (sense/anti-sense):
Multiplex (662 bp), GCCGCTACATCATAGCCATC / GCTCTCTCCAATGCTCTCCTC;
Nested (506 bp), ACATGGTCAACAACAGCACTATC / ATAAGACACCAGAAGCCAGAACA;
Th (sense/anti-sense):
Multiplex (692 bp), GCCGTCTCAGAGCAGGATAC / TGGGTAGCATAGAGGCCCTT;
Nested (179 bp), GTCTCAGAGCAGGATACCAAGC / CTCTCCTCGAATACCACAGCC;QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was performed using MATLAB and GraphPad. All statistical tests were two-sided. The 95% confidence intervals
(CI) for brain state probabilities and transition probabilities were calculated using a bootstrap procedure: For an experimental group
of nmice, with mouse i comprisingmi trials, we repeatedly resampled the data by randomly drawing for eachmousemi trials (random
sampling with replacement). For each of the 10,000 iterations, we recalculated the mean probabilities for each brain state and each
transition across the n mice. The lower and upper confidence intervals were then extracted from the distribution of the resampled
mean values. To test whether a given brain state or state transition is significantly modulated by laser stimulation, we calculated
for each bootstrap iteration the difference between the mean probabilities during laser stimulation and the preceding period of iden-
tical duration (combining all time bins within each period). The p value was determined from the distribution of the differences in
10,000 iterations. To compare the degree of laser-induced brain state changes between two groups of animals, in each iteration
we resampled the data for each group separately. The laser effect (difference between the pre-laser and laser periods) was computed
for each group, and the difference between the two groups was computed. The p value was determined from the distribution of the
differences in 10,000 iterations.
DATA AND SOFTWARE AVAILABILITY
Processed and raw data of TRAP RNA-seq have been deposited in the Gene Expression Omnibus under accession number
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